Orbital fat loss happens when the cushioning fat around your eyeball shrinks or breaks down, creating a sunken, hollowed-out appearance around the eyes. The causes range from normal aging to specific medications, medical conditions, trauma, and surgery. Understanding which factor is driving the change matters because some causes are reversible or preventable.
How Orbital Fat Works
Your eye socket contains pads of fat that cushion the eyeball, keep it positioned correctly, and give the area around your eyes its fullness. These fat pads sit in distinct compartments held in place by ligaments and connective tissue. When the fat in these compartments shrinks, the eye appears to sink backward (a condition called enophthalmos), the upper eyelid crease deepens, and the area beneath the brow looks hollow.
Aging
Age is the most common cause of orbital fat loss. As you get older, the fat pads gradually atrophy and the ligaments supporting your eyeball stretch and weaken. The Lockwood suspensory ligament, which acts like a hammock under the eye, descends over time. When this happens, the eyeball drops slightly within the socket, compressing fat against the orbital floor. That compression pushes some fat forward (creating under-eye bags) while reducing the overall volume that keeps the eye area looking full.
Genetics play a significant role in the timeline. Some people develop noticeable hollowing in their 30s or 40s, while others retain orbital volume well into their 60s. The process is gradual enough that many people don’t notice it until photographs reveal the change over several years.
Glaucoma Eye Drops
Certain glaucoma medications are one of the most significant and underrecognized causes of orbital fat loss. Prostaglandin analog eye drops, the most commonly prescribed class of glaucoma treatment, can shrink orbital fat over months to years of use. The condition is called prostaglandin-associated periorbitopathy, and it produces a visibly sunken eye appearance with deepening of the upper eyelid crease.
The three main drugs in this class are bimatoprost, travoprost, and latanoprost. Among them, bimatoprost carries the highest risk, with orbital fat changes reported in more than 10 percent of patients. The mechanism likely involves the drug blocking the formation of new fat cells in the orbital compartments. Periorbital fat loss was the single most frequent finding among prostaglandin-treated patients in clinical studies, with the exception of relatively young users.
If you use glaucoma drops and notice one or both eyes looking increasingly hollow, this is worth raising with your eye doctor. The effect can sometimes be reduced by switching to a different medication, and some of the changes may partially reverse after stopping the drops.
Medical Conditions
Several systemic and localized conditions cause the body to lose orbital fat:
- Parry-Romberg syndrome (progressive hemifacial atrophy): A rare condition where the tissue on one side of the face gradually wastes away, including the fat around the eye. It typically begins in childhood or adolescence and progresses over several years before stabilizing.
- Scleroderma: This autoimmune condition causes hardening and tightening of skin and connective tissue. When it affects the face (particularly the localized form called linear scleroderma), it can destroy orbital fat on the affected side.
- Silent sinus syndrome: Chronic, often painless inflammation in the maxillary sinus causes the orbital floor to slowly bow inward. The eye gradually sinks as the socket effectively enlarges. Many people don’t realize anything is wrong until the asymmetry between their eyes becomes obvious.
- Systemic lipodystrophy: Conditions that cause widespread fat loss throughout the body affect orbital fat as well, sometimes dramatically.
These conditions typically cause asymmetric hollowing, meaning one eye looks noticeably different from the other. That unevenness is often what prompts people to seek medical attention.
Trauma and Radiation
Blunt force injuries to the eye socket can damage orbital fat directly through fat necrosis, where the tissue dies and is gradually absorbed by the body. Orbital fractures, particularly blowout fractures of the thin orbital floor, can allow fat to herniate into the sinus cavity below, permanently reducing the volume around the eye.
Radiation therapy to the face or orbit, used for certain cancers, can also destroy orbital fat over time. The damage is progressive and may not become fully apparent until months or years after treatment ends. Orbital varix, an abnormal swelling of veins within the eye socket, is another documented cause of fat atrophy in the surrounding tissue.
Cosmetic Surgery
Blepharoplasty (eyelid surgery) is one of the most popular cosmetic procedures, but removing too much fat during the operation creates a hollow, aged appearance that can be very difficult to correct. Experienced surgeons now tend to err on the side of preserving orbital fat rather than removing it, because the hollowed “A-frame deformity” that results from over-resection often looks worse than the original puffiness the surgery was meant to fix.
This is a permanent change. Once orbital fat is surgically removed, it does not regenerate on its own.
Weight Loss
Significant weight loss affects facial fat in a specific pattern. The superficial fat compartments, those closer to the skin surface, shrink first. Research on patients after bariatric surgery found that superficial cheek fat decreased by nearly 70 percent and the superficial temporal fat pad shrank by about 42 percent during the weight loss period.
Deep orbital fat appears to be more resistant to weight loss than superficial facial fat, likely because deep compartments have a more robust blood supply and are less metabolically active. However, no clinical study has directly measured orbital fat volume changes after major weight loss. In practice, extreme weight loss can make the eyes look more sunken, though this likely reflects loss of the surrounding superficial fat rather than the deep orbital pads themselves.
How Orbital Fat Loss Is Treated
Treatment depends on the cause and severity. For medication-related fat loss, stopping or switching the drug is the first step, and some volume may return naturally. For all other causes, restoring lost volume requires either injectable fillers or fat grafting.
Hyaluronic acid fillers are the less invasive option. They produce high patient satisfaction rates (85 to 90 percent in studies of tear trough correction) and the results typically last 8 to 12 months, though some techniques have shown effects persisting up to 36 months on imaging. Younger patients tend to see longer-lasting results. The main advantage is that the filler can be dissolved if the result isn’t right.
Fat grafting uses fat harvested from another part of your body, usually the abdomen or thighs, and injects it into the orbital area. It offers longer-lasting results, up to three years or more in some cases. The trade-off is unpredictability: the body reabsorbs anywhere from 20 to 80 percent of the transferred fat, making the final outcome harder to control. Newer processing techniques that concentrate the stem cell component of the fat have shown retention rates closer to 80 percent, which is a significant improvement.
For structural causes like silent sinus syndrome, treating the underlying sinus problem is necessary before any volume restoration will hold. For conditions like Parry-Romberg syndrome, treatment is usually delayed until the disease has stabilized.